CancerDrs

Brain Cancer clinical trials in Nebraska

8 actively recruiting brain cancer trials at 5 sites across Nebraska.

Data from ClinicalTrials.gov · last refreshed

Phase 3 Recruiting Network

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

This trial has two cohorts of patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. All patients must be receiving trastuzumab-based treatment. Both cohorts are bei…

Sponsor: SWOG Cancer Research Network
NCT ID: NCT03418961
Sites in Nebraska:
  • CHI Health Saint Francis — Grand Island, Nebraska
  • Heartland Hematology and Oncology — Kearney, Nebraska
  • CHI Health Good Samaritan — Kearney, Nebraska
  • Saint Elizabeth Regional Medical Center — Lincoln, Nebraska
  • Alegent Health Immanuel Medical Center — Omaha, Nebraska
View on ClinicalTrials.gov →
Phase 3 Recruiting Network

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

This phase III trial tests two hypotheses in patients with low-risk and average-risk medulloblastoma. Medulloblastoma is a type of cancer that occurs in the back of the brain. The term, risk, refers to the chance of the cancer coming back …

Sponsor: Children's Oncology Group
NCT ID: NCT05382338
Sites in Nebraska:
  • Children's Hospital and Medical Center of Omaha — Omaha, Nebraska
  • University of Nebraska Medical Center — Omaha, Nebraska
View on ClinicalTrials.gov →
Phase 3 Recruiting Industry

ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)

This is a randomized, double-blind, placebo-controlled, parallel-group, international, Phase 3 study in patients with newly diagnosed H3 K27M-mutant diffuse glioma to assess whether treatment with dordaviprone (ONC201) following frontline …

Sponsor: Jazz Pharmaceuticals
NCT ID: NCT05580562
Sites in Nebraska:
  • University of Nebraska Medical Center — Omaha, Nebraska
View on ClinicalTrials.gov →
Phase 2 Recruiting Academic/Other

A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease

This study is being done to see if adding GLIADEL to the site where the tumor was removed works as well as just having the tumor removed with radiation treatment done within six weeks after the surgery to keep the cancer from coming back.

Sponsor: University of Nebraska
NCT ID: NCT04222062
Sites in Nebraska:
  • University of Nebraska Medical Center — Omaha, Nebraska
View on ClinicalTrials.gov →
Phase 1 Recruiting Industry

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

A Phase 1 Open-Label, First-in-human, Dose Escalation and Expansion Study to Determine the Safety, Tolerability, Dosimetry, Pharmacokinetics, and Preliminary Efficacy of 212Pb-DOTAM-GRPR1 in Adult Participants with Recurrent or Metastatic …

Sponsor: Orano Med Theranostics, SAS
NCT ID: NCT05283330
Sites in Nebraska:
  • Nebraska Cancer Specialists (Midwest Cancer Center - Legacy) — Omaha, Nebraska
  • XCancer Omaha / Urology Cancer Center — Omaha, Nebraska
View on ClinicalTrials.gov →
Phase 1 Recruiting Academic/Other

A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma

Glioblastoma (GBM), WHO grade IV glioma, represents the majority of adult malignant primary brain tumors, with an incidence of 2-3 per 100,000 person-years. The survival for GBM has increased in the last decade but is still low with a medi…

Sponsor: University of Nebraska
NCT ID: NCT05698524
Sites in Nebraska:
  • University of Nebraska Medical Center — Omaha, Nebraska
View on ClinicalTrials.gov →
Recruiting Academic/Other

Assessment of Eloquent Function in Brain Tumor Patients

Purpose of the study: AIM 1: Prospectively collect pre-operative \[functional magnetic resonance imaging (fMRI), diffusion tensor imaging (DTI), magnetoencephalography (MEG)\] and intra-operative mapping data in patients with intra-axial b…

Sponsor: University of Nebraska
NCT ID: NCT01535430
Sites in Nebraska:
  • University of Nebraska Medical Center — Omaha, Nebraska
View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-10-19